Preview

Nephrology and Dialysis

Advanced search

Multiple myeloma in Baikal region: frequency of kidney involvement and risk factors of kidney dysfunction

Abstract

The aim of the study was to evaluate the incidence of kidney disease in multiple myeloma (MM) patients in Baikal region and to determinate the independent predictors of renal insufficiency (RI) and its progression. 102 patients with multiple myeloma were examined. Forms, stage, degree of risk, immunochemical variants and MM course, β2 blood microglobulin, SRB were determined. Kidney function was examined at the moment of disease diagnostics and during treatment: serum creatinine level, glomerular filtration rate (GFR) by Cockcroft-Gault formula, were examined. At the moment of MM diagnostics 32% of all patients have had kidney dysfunction, 63% of all patients have had GFR < 29 ml per min. The highest MM frequency with RI in debut of disease fall at the age of 60-69 years, women prevail. The majority of RI patients in debut of disease have III stage of MM (47% of all), progressing course (47% of all), high degree of risk (50% of all), BJ variant (44% of all). BJ λ (57%) prevails among BJ variant. The majority of patients with RI in debut of disease had Hb < 85 g/l. 59% of all patients had high level of СRB, 56% had increase of β2 microglobulin. Conclusion : High risk of kidney dysfunction take place while revealing III stage of MM with progressive course, high degree of risk of MM progression, BJ λ variant, anemia with Hb < 85 g/l and with increasing of СRB.

About the Authors

O. M. Senderova
Иркутская областная клиническая больница
Russian Federation


G. M. Orlova
Иркутский государственный медицинский университет; г. Иркутск
Russian Federation


References

1. Андреева Н.Е. Диагностика и лечение множественной миеломы. М.: Новартис 2001: 28.

2. Абдуллаев О.М. Синдром повышенной вязкости при парапротеинемических гемобластозах и влияние на него интенсивного плазмафереза: Автореф. дисс.. канд. мед. наук. М.: 1987.

3. Абдулкадыров К.М., Бессмельцев С.С. Основные механизмы развития почечной недостаточности и методы ее коррекции при множественной миеломе. Терапевт. арх. 1992; 6: 85-89.

4. Абдулкадыров К.М., Бессмельцев С.С. Диагностика и лечение множественной миеломы. Методические рекомендации. СПб.: 1993: 22.

5. Белков С.А. Прогностическое значение содержания креатинина в периферической крови у больных множественной миеломой. Нефрология и диализ 2005; 7; 2: 169.

6. Гордовская Н.Б. Поражение почек при множественной миеломе. Терапевт. Арх. 1995; 6: 71-76.

7. Камаева О.И. Миеломная болезнь и почки. Тер. арх. 1997; 6: 73-76.

8. Ткаченко Н.Я. Острая почечная недостаточность как проявление миеломной почки в сочетании с болезнью депонирования моноклональных иммуноглобулинов. Нефрология и диализ 2005; 7; 1: 64-69.

9. Cuzick J., Galton D.A.G. Prognostic features in the third MRC myelomatosis trial. Br J Cancer 1980; 42; 6: 831-840.

10. Ganeval D., Hoel L. N. et al. Light-chain deposition deasease: New insights into old entity. Kidn Int 1999; 56: 355-377.

11. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Amer J Kidney Dis 1992; 20: 1-17.


Review

For citations:


Senderova O.M., Orlova G.M. Multiple myeloma in Baikal region: frequency of kidney involvement and risk factors of kidney dysfunction. Nephrology and Dialysis. 2006;8(1):59-63. (In Russ.)

Views: 6


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1680-4422 (Print)
ISSN 2618-9801 (Online)